Business Wire

C-LECTA

6.6.2019 08:02:07 CEST | Business Wire | Press release

Share
c-LEcta: Financial Figures for 2018 Underscore Successful Transformation into a Product Company

c-LEcta, a globally operating biotechnology company with technology leadership in the fields of enzyme engineering and bioprocess development, has successfully developed its business model into an international product company in fiscal year 2018. The focus was on products for regulated markets such as the food and pharmaceutical industries. Total sales in fiscal 2018 amounted to EUR 4.5 million.

Sales of in-house developed products increased by more than 70% in fiscal year 2018. This accounted for around two thirds of the company’s revenues. In the product business, c-LEcta manufactures and markets its own biotechnological products. At present, the focus here is on enzyme products that make industrial food and pharmaceutical production more efficient as processing aids. In the future, biotechnologically produced and finished ingredients for applications in the food and cosmetics sectors will also be added as products. The project business is the second source of sales. Here, c-LEcta works in strategic partnership with leading companies from the food and pharmaceutical industries, for example, on the development, commercialization and marketing of jointly developed products. As planned, the share of project business fell to around one third of total sales in fiscal 2018. In the course of this development, c-LEcta was able to further diversify its own product portfolio and achieved around 70% of product sales with three different products. In fiscal year 2017 a single, highly successful product was still responsible for this share of sales. As a result, c-LEcta is more independent of individual products and gains greater sales stability for the coming years. In addition, the company laid the foundation for further growth in the dynamic market for food ingredients. More than two thirds of sales in fiscal year 2018 were already generated in this area. The remainder of sales came mainly from products for the pharmaceutical market.

“In the past fiscal year, we focused on developing c-LEcta into a product company. Our rapidly growing product business gives us access to new customers. We are convinced that our core market for food ingredients still offers great potential for our unique biotechnology solutions. With the transformation of our company strategy, we have laid the foundation to realize this potential,” said Marc Struhalla, founder and CEO of c-LEcta.

In fiscal year 2018, c-LEcta invested in personnel expansion, in particular. Thus, the company laid the foundation stone to suit its increased activities in marketing its own products and further growth. At the end of 2018, 63 employees were working for c-LEcta, eight more than at the end of the previous year. The site area was expanded by around 800 m2 to a total area of 3,100 m2 . The company also invested in property, plant and equipment for research and development and in production facilities.

“The past fiscal year was marked by many positive changes. As an innovative company with customers from 25 countries on four continents, we have a broad international base. The investments we made have also helped us to diversify our products. The financial resources from the last successful round of financing give us the freedom to push ahead with our growth strategy in the current fiscal year,” explains Thomas Pfaadt, CFO of c-LEcta.

For the current fiscal year, the management expects further expansion of the product business and plans more investments in growth.

About c-LEcta

c-LEcta is a world-leading biotechnology company with a focus on enzyme engineering and application in regulated markets like the food and pharma industries. The company is based in Leipzig, Germany, and has established itself as a leading player in the realization of high-value biotech products, either in the form of in-house developments or in close cooperation with industry. The company currently employs more than 60 people.

c-LEcta delivers cost-efficient and sustainable production processes which open new markets and allow for better penetration of existing markets. The company is characterized by fast and efficient development of best-in-class biotech solutions and a rapid and successful market introduction and commercialization of the resulting products. This enables c-LEcta to leverage the unique potential of its core technologies. c-LEcta has a proven track record of more than ten successfully commercialized high-value industrial biotech products.

Contact:

cometis AG Maximilian Franz Phone: +49 (0) 611 - 205855 – 22 Fax: +49 (0) 611 - 205855 – 66 e-mail: franz@cometis.de

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OCP Announces Date of Third Quarter and Nine-Month 2026 Earnings19.11.2026 17:30:00 CET | Press release

OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its third quarter and nine-month 2026 results on Monday, November 30, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 7:00 a.m. EDT, 12:00 p.m. Morocco and London time (GMT). OCP senior management will host a conference call to discuss third quarter and nine-month 2026 results at 8:00 a.m. EDT, 1:00 p.m. Morocco and London time (GMT) on Monday, November 30, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century’s production history. OCP has exclusive ac

ISACA Launches Updated COBIT 7 With Enhanced Assessment Model and Modern Digital Platform19.11.2026 16:24:00 CET | Press release

Refreshed framework reflects today’s technology landscape with streamlined design guidance, refreshed objectives and three levels of organizational assessment When AI can spark fears about humanity’s future and aging technology can bring air travel to a standstill, the cost of weak governance is impossible to ignore. To help enterprises strengthen the governance of their information and technology, ISACA has launched COBIT 7, an updated version of its globally recognized framework for information and technology (I&T) governance. Built for a rapidly changing digital world, the new COBIT 7 framework combines trusted guidance, an intuitive digital platform, customizable resources, and practical tools to help practitioners turn technology into measurable value, align decisions with strategy and confidently navigate emerging risks, including AI. COBIT 7 reinforces the framework’s longstanding role in helping businesses align their I&T operations with broader strategic goals, manage technolo

North Star Carbon Removal Project Selected by Government of Canada for Landmark Carbon Removal Procurement Program19.11.2026 16:04:00 CET | Press release

Microsoft-backed Saskatchewan project developed by MLTC and Svante among only three BECCS projects selected North Star, a planned large-scale carbon dioxide removal (CDR) project being developed by Meadow Lake Tribal Council (MLTC) and Svante Technologies Inc. (Svante), has been selected by the Government of Canada as a qualified supplier under the federal Request for Standing Offer (RFSO) for the Acquisition and Retirement of Credits from Carbon Dioxide Removal Projects. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261118228180/en/ The proposed North Star bioenergy with carbon capture and storage project is being developed by the Meadow Lake Tribal Council (MLTC) and Svante. The project will generate durable carbon dioxide removal credits by capturing biogenic CO2 from the MLTC Bioenergy Center in Meadow Lake, SK, Canada, and storing it deep underground in a geological storage site. North Star was one of only three bioene

Xsolla Gives Games a New Home for Their Players on Desktop and the Web, With Rewards to Help Bring Players Back19.11.2026 15:32:00 CET | Press release

Developers Can Now Reach Players on Desktop and the Web With Xsolla Player and Xsolla Pages Xsolla (USA), Inc., a global commerce company, is giving game developers two new capabilities designed to reach players and encourage repeat engagement. Xsolla Player and Xsolla Pages are now available, letting developers integrate quests, rewards, and partner-funded offers into the player flow. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261119175727/en/ Graphic: Xsolla Xsolla Player is a desktop app that players install once and access with their Xsolla ID, bringing their game library and inventory together without separate sign-ups for each game. Xsolla Pages creates search-optimized storefronts on the web for every title in a developer’s catalog, with direct checkout. PC studios work hard to win a player's first click, then work just as hard for every session after. Bringing players back is a challenge and has traditionally req

From London 1851 to Riyadh 2030: The United Kingdom Continues Its World Expo Legacy with the Signing of Its Participation Contract for Expo 2030 Riyadh19.11.2026 15:10:00 CET | Press release

The United Kingdom has signed its Participation Contract for Expo 2030 Riyadh, confirming its place at one of the world’s largest global gatherings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261119617914/en/ The Participation Contract was signed by H.E Adel Al-Jubeir, Minister of State for Foreign Affairs, Climate Envoy, and Commissioner General of Expo 2030 Riyadh; and Lord Sarwar, UK Minister for Trade; and Talal Al-Marri, CEO of Expo 2030 Riyadh. The Agreement constitutes a significant milestone in the United Kingdom’s journey towards Expo 2030 Riyadh, establishing the framework for the execution of its pavilion, programming and visitor experience. This latest agreement adds to a growing number of Participation Contract signings, reflecting increasing momentum behind Expo 2030 Riyadh and the value countries are placing on being part of it. The Participation Contract was signed by H.E Adel Al-Jubeir, Minister of State

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye